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Two mouse genornic DNA sequences homologous with human ~~i~tropin~-~~~opin precursor gene 
sequences have been cloned. One of them represents he functional ~~~trop~-~-~~~op~ precursor 
gene, which exhibits a structural orgauization similar to those of its bovine and human counterparts. The 
other represents a pseudogene that corresponds to the functional mouse gene sequence ncoding the 
carboxy-terminal 143 amino acid residues (including corticotropin and @-lipotropin) and the 
3 ’ -untranslated region. 
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1. INTRODUCTION 
The primary struct~e of the boron precursor 
of corticotropin (ACTH) and &lipotropin (&- 
LPH) has been deduced from the nucleotide se- 
quence of cloned DNA complementary to its 
mRNA [l] which was purified from the bovine 
pituitary intermediate lobe [Z], With the use of 
cDNA probes, the whole bovine and human 
ACTH-&LPH precursor genes have been isolated, 
and their structural organizations have been 
elucidated [3-61. Both genes consist of 3 mRNA- 
coding segments (designated as exon 1, exon 2 and 
exon 3 in the 5 * to 3 ’ direction on the message 
strand) divided by two large intervening sequences 
(designated as intron A and intron B in the same 
direction). Intron A is inserted within the segment 
corresponding to the 5 ’ -untranslated region of the 
* To whom correspondence should be addressed 
Abbreviations: ACTH, corticotropin; &LPH, 
@-lipotropin 
mRNA, and intron B within the protein-coding se- 
quence near the signal peptide region. This in- 
vestigation deals with the cloning and sequence 
analysis of the mouse ACM-I-&LPH precursor 
gene and a mouse pseudogene related to it. 
2. MATERIALS AND ~THODS 
The gene library used, which was a kind gift 
from Dr T. Honjo and Dr T. Kataoka, was a col- 
lection of recombinant phage that carried mouse 
MPCl 1 myeloma DNA fragments generated by 
partial digestion with EcoRI and joined to the h 
Charon 4A arms [7]. Screening of phage was per- 
formed as in [8]; the hybridization probes were 
labelled with [or-32P]dCTP by nick-translation [PI. 
Cellular DNA was prepared by the procedure/ in 
[lo] and total RNA by the procedure in [ll]. 
Restriction endonuclease mapping and blot 
hybridization analysis were conducted as in [3] and 
SI nuclease mapping as in 1121. DNA sequencing 
was carried out by the procedure in [13], Reagents 
were obtained as in [3]. 
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3. RESULTS AND DISCUSSION 
A mouse genomic DNA library [7] was screened 
for phage carrying ACTH-&LPH precursor gene 
sequences by hybridization in situ at 60°C with 
32P-labelled human genomic DNA probes. Using 
the 657 basepair SmaI-Sati fragment derived from 
exon 3 of the human ACTH-,&LPH precursor 
- 
Fig.1. Restriction endonuclease mapping of cloned 
mouse genomic DNA segments containing the 
ACTH-,&LPH precursor gene and the pseudogene and 
sequencing strategy: (A) 9700 basepair EcoRI fragment 
containing the ACTH-,&LPH precursor gene; (B-D) 
portions of the 9700 basepair EcoRI fragment 
containing exon 1, exon 2 and exon 3, respectively; (E) 
5600 basepair EcoRI fragment containing the 
pseudogene; (F) a portion of the 5600 basepair EcoRI 
fragment containing the sequence homologous with the 
functional gene sequence. The direction of transcription 
is from left to right. Scales are given in basepairs (bp) on 
the right side of each restriction map. For reference, the 
locations of the exons and the pseudogene are shown by 
closed and open boxes, respectively. Only the relevant 
restriction sites are displayed for: AM, Fnu4HI and 
Me111 (B); AM, BstNI, Fnu4H1, NhuI and HprII (D); 
DdeI, HaeIII and E&r11 (F). The horizontal arrows 
beneath the restriction maps in B-D and F indicate the 
direction and extent of sequence determinations. 
gene [4] as a probe, we isolated 41 hybridization- 
positive clones from -5 x lo6 plaques. These 
clones were rescreened by hybridization with the 
172 basepair A WI fragment containing most of ex- 
on 1 and its preceding region [4] or with the -790 
basepair BarnHI-HinfI fragment containing exon 
2 and its flanking regions [4]. Ten (first type) of the 
41 clones hybridized with both the exon 1 and exon 
2 probes, while the remaining 31 clones (second 
type) did not hybridize with either probe. Blot 
hybridization analysis of DNA prepared from 2 
clones of the first type and 3 clones of the second 
type showed that the former clones carried a com- 
mon EcoRI fragment of -9700 basepairs, while 
Fig.2. Nucleotide sequence of the exons and their surrounding regions of the mouse ACTH-fl-LPH precursor gene 
aligned with that of the pseudogene. The nucleotide sequence of the message strand of the functional gene, together 
with the deduced amino acid sequence, is shown; the sequences of the exons and their surrounding regions are 
represented by large and small capital letters, respectively; the amino acid residues are numbered beginning with the 
tryptophan residue specified by the 27th codon, and the preceding residues constituting the signal peptide [14] are 
indicated by negative numbers. The exon/intron junctions are positioned according to the GT/AG rule [IS]. The 
putative sites of capping and poly(A) addition are indicated. The TATA box and the CAAT box are enclosed with 
boxes. The nucleotide sequence of the pseudogene, aligned with that of the functional gene, is shown beneath the latter; 
the homologous pseudogene sequence and its flanking sequences are represented by large and small capital letters, 
respectively. The colons indicate identical nucleotides in the two sequences. The amino acid differences anticipated from 
the pseudogene sequence are shown for the homologous region; Ter denotes a translational termination codon, and the 
absence of an amino acid indicates that an identical residue is specified by the functional gene and the pseudogene. The 
pseudogene segment composed mainly of repeated GA dinucleotides is underlined. The 10 basepair direct repeats are 
indicated by thick arrows beneath the sequences. 
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:” 4” 60 I "I" '?" 
Functional gene 5'---------CTCAGAACTAGGCCTGCCTCGCACAGGGACGCTAAGCCTCTGTCCAGTTCTAAGTGGAGATTCAACACCATT 
CTTAATTAAGTTCTTCCTAACCACCAGCGCCAGGTGTGCGCTTCAGCGGGTCTGTGCTAACGCCAGCCTCCGCGCTTTCCAGGCAGATGTGCCTTGCGCT 
TTTGTCCCCAGAGAGCTGCCTTTCCGCGACAG GTAAGGGTGTCTCAGCTCTGGACAGCTCCCTTACTCTGAGCTCTGACCCCGGACCTTGGGATCC---- 
-26 -20 -10 
MetProArgPheCysTyrSerArgSerGlyAlaLeuLeuLeuAlaLeuLeuLeuGlnTh,r 
CTTGTTTGCCTCTGCAGAGACTAGGCCTGACACGTGGAAGATGCCGAGATTCTGCTACAGTCGCTCAGGGGCCCTGTTGCTGGCCCTCCTGCTTCAGACC 
-1 1 10 18 
SerIleAspValTrpSerTrpCysLeuGluSerSerGlnCysGlnAspLeuThrThrGluSerAsnLeuLeu 
TCCATAGATGTGTGGAGCTGGTGCCTGGAGAGCAGCCAGTGCCAGGACCTCACCACGGAGAGCAACCTGCTG~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 
TTGGGTGGAAGATGGCATCGGGGTTAGTACAGAGCAAAGGGAAGAGGGCCGTGGGAAGAGGTGC-----------(IntrOn B)-----------GC~A 
19 30 ’ 40 
AlaCySIlsArgAlaCySLysLeuAspLeuSerLeuGluThrProValPheProGlyAsnGlyAspG~u 
GGCTTGGCT~ACT~GCCTGG~~T~~~TACAGGCTTGCATCCGGGCTTGCAAACTCGACCTCTCGCTGGAGACGCCCGTGTTTCCTGGCAACGGAGATG~A 
: :: : . :: : : : : : ~ 
pseudogene 5'---------TTATTGAAGTATCTTAAAGCCTTCACATGAGAAAATC'rTGA~AGGCACACTTATCTATCCAGATTTTCATGACTACT 
50 60 70 
GlnProLeuThrGluAsnProArgLysTyrValMetGlyHisPheArgTrpAspArgPheGlyProArgAsnSerSerSerAlaGlySerAlaAlaGl A 
CAGCCCCTGACTGAAAACCCCCGGAAGTACGTCATGGGTCACTTCCGCTGGGACCGCTTCGGCCCCAGGAACAGCAGCAGTGCTGGCAGCGCGGCGCAaA 
SO 90 100 
rgArgAlaGluGluGluAlaValTrpGlyAspGlySerPsoGluProSerPKOArgGluGlyLysArgSsrTyrSerMstGluHisPheArgTrpGly'y 
GGCGTGCGGAGGAAGAGGCGGTGTGGGG4GATGGCAGTCCAGAGCCGAGTCCACGCGAGGGCAAGCGCTCCTACTCCATGGAGCACTTCCGCTGGGGC~A 
ArgLeu LsU serpro CYS His 
110 120 130 140 
sProValGlyLysLysArgArgProVslLysValTyrProAsnValAlaGluAsnGluSerAlaGluAlaPheProLeuGluPheLysArgGluLsuG u 
GCCGGTGGGCAAGAAACGGCGCCCGGTGAAGGTGTACCCCAACGTTGCTGAGAACGAGTCGGCGGAGGCCTTTCCCCTAGAGTTCAAGAGGGAGCTGG~A 
::::::::::::::: : : :: ::: :::::::::::::: :: :: : : :::::::: ::::::::::::::::::::::::::::::::::::::::::i: 
GCCGGTGGGCAAGAAGCGGCTCCCAGTGAAGGTGTACCCTAATGTTGCTGAGAACAAGTCGGCGGAGGCCTTTCCCCTAGAGTTCAAGAGGGAGCTGGAA 
LsU LYs 
150 160 170 
GlyGluArgProLeuGlyLeuGluGlnValLeuGluSerAspAlaGluLysAspAspGlyProTyrArgValGluHisPheArgTrpSerAsnProPr L 
GGCGAGCGGCCATTAGGCTTGGAGCAGGTCCTGGAGTCCGACGCGGAGAAGGACGACGGGCCCTACCGGGTGGAGCACTTCCGCTGGAGCAACCCGCC~A 
::: ::::::: ::::::::::: : : ::::::::::::::: :::::::: ::::::::: :::::::::::: ::::::::: :::::: ::::: 
GGCAAGCGGCCTGATGGCTTGGAGCACGTCCTGGAGTCCGACGCCCAGAAGGACAACGGGCCCTGCCGGGTGGAGCATTTCCGCTGGGGCAACCTGCCCA 
LYS A=P His Gln ASn CYS Gly Leu 
180 190 200 
ysAspLysArgTy+GlyGlyPheMetThrSs~GluLysSsrGlnThrProLsUVslTh~LsuPhsLysAsnAlsIleIleLysAsnAlaH~sLysLys 1 
AGGACAAGCGTTACGGTGGCTTCATGACCTCCGAGAAGAGCCAGACGCCCCTGGTGACGCTCTTCAAG~CGCCATCATCAAGAACGCGCACAAG~G~G 
:: :::::::::: ::::::::::::::::::::::::::::::::::::::::::: ::::::::::::::: ::::::::::: : ::::::::::: 
AGAACAAGCGTTAAGGTGGCTTCATGACCTCCGAGAAGAGCC,4GACGCCCCTGGTGATGCTCTTC~GAACGCCTTCATCAAGAACACACACAAGAAGGG 
ASn TsK Met Phe Thr 
209 
yGlnTer 
CCAGTGAGGGTGCAGGGGTCTTCTCATTCCAAGGCCCCCTCCCTGCATGGGCGAGCTGATGACCTCTAGCCTCTTAGAGTTACCTGTGTTAGGAAATA~ 
:: :: :: :::::::::::::::::::: ::::::::::::::::::: :: ::::::: :: : : :::::::::::::::::::::::::::::::::::::: 
CCAGTGAGGGTGCAGGGGTCTTCTCACTCCAAGGCCCCCTCCCTGCGTGAGCGAGCTAATGACCTCTAGCCTCTTAGAGTTACCTGTGTTAGGAAATA19A 
Poly (A) 
ACCTTTC~GATTTCACAGTCGGCT~TGATCTTCAATAAAAACTGCGTAAATAAAGTCAAAACACAACTGTCCAGTTACACTATCACGTGACCAGATGCTA 
: : ::::::::: 
ACCTTTCAGATGAG~G~~AGC~AGAGAGAGAGAG~G~G~G~GA~A~GGGGGG~GAGAG~G~G~G~GAGAGAG~~AG~G~GAGAG~GAGAGAG~~~GAG~AG 
GAATGTAAAGAAAACATTTCTCAACCTCCTTGCCCCAGCAA---------3' 69 : : . : : : 
AGAGAGGAGAGGAGAGAGAGAGAGGGTTTTCTCAGTGCTTCCCAAGTGAGTGGATTATTATTTATTTAATGGTGAAT---------3' 
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the latter clones harboured acommon EcoRI frag- 
ment of -5600 basepairs. The sizes of these EcoRI 
fragments agree with those of the two 
hyb~~zation-positive EcoRI fragments detected 
by blot hybridization analysis of cellular DNA 
(isolated from BALB/c mouse livers and cultures 
of the ACTH-producing mouse pituitary tumor 
cell line AtT-20/D-16v). The two EcoRI fragments 
from the recombinant phage were subcloned in 
plasmid pBR322 for further analysis. 
Fig. 1A and E show restriction maps of the clon- 
ed 9700 basepair and 5600 basepair EcoRI 
fragments, respectively. The hybridization-positive 
DNA segments and their surrounding regions were 
subjected to nucleotide sequence analysis accor- 
ding to the strategy illustrated in fig.lB-D and F. 
Comparison of the determined sequences with the 
bovine and human ACTH-&LPH precursor gene 
sequences [3,4] clearly indicated that the 
homologous mouse sequence contained in the 9700 
basepair E’coRI fragment represents he functions 
ACTH-&LPH precursor gene, while that in the 
5600 basepair EcoRI fragment represents a 
pseudogene. The two mouse sequences are aligned 
in fig.2. 
The functional mouse ACTH-,&LPH precursor 
gene contains two introns as identity by com- 
parison with its bovine and human counterparts 
[3,4] and with the cDNA for the mouse ACTH-,& 
LPH precursor reported in [16]. Intron A, -3000 
basepairs long, interrupts the segment encoding 
the 5 ‘-untranslated region between 23 and 24 
basepairs upstream of the tr~slation~ i~tiation 
site. Intron B, -1700 basepairs long, is inserted in 
the protein-coding region, separating the segment 
encoding the amino-terminal 44 amino acids in- 
cluding the signal peptide from that encoding the 
remaining 191 amino acids and the 3 ‘-untranslated 
region. Thus, the mouse ACTH-&LPH precursor 
gene, consisting of 3 exons, exhibits a structural 
organization similar to those of its bovine and 
human counterparts. The capping site and the po- 
ly(A) addition site of the mouse gene have ten- 
tatively been assigned by comparison with the 
bovine and human genes [3,4] and with the mouse 
cDNA 1161, respectively. The assignment of the 
capping site is supported by Sr nuclease mapping 
using total RNA from cultured AtT-20/D-l& cells 
and the 162 basepair Pstl-A&I fragment (5 ‘-end- 
labelled at the AluI site; see fig.lB). A putative 
70 
TATA box [ 171 and a putative CAAT box [ 181 are 
found 25 basepairs and 59 basepairs upstream of 
the capping site assigned, respectively. Com- 
parison of the nucleotide sequence of the mouse 
ACTH-,&LPH precursor gene with that of the 
mouse cDNA 1161, cloned with the use of the 
mRNA from the cell line AtT-20/D-16v, shows 
some nucleotide differences, two of which result in 
amino acid replacements (Ser instead of Arg at 
residue 19; His instead of Gln at residue 150). The 
observed nucleotide differences may be due to 
possible heterogeneity in the mouse ACTH-,& 
LPH precursor gene or to possible rrors introduc- 
ed during DNA cloning. 
The pseudogene exhibits a nucleotide sequence 
highly homologous with the 3 ‘-terminal 533 
basepairs of the functional gene, which constitute 
a large portion of exon 3 including the coding 
regions for ACTH (residues 98-136) and ,&LPH 
(residues 139-209). The degree of homology is 
92%, and neither in~~ions nor deletions are 
found. Many of the nucleotide substitutions, 
however, would result in amino acid replacements, 
for example, the replacement of Arg (residue 97) 
by Cys, which would abolish the Lys-Arg pair ser- 
ving as a signal for proteolytic processing [19] to 
produce ACTH, and the introdu~ion of a transla- 
tional termination codon at position 179 (instead 
of Tyr), which would lead to premature termina- 
tion at the amino terminus of ,&endorphin 
(residues 179-209). Thus, the pseudogene cannot 
encode a functional precursor protein like the 
ACTH-&LPH precursor. 
The sequence homology between the functional 
gene and the pseudogene ends, on the 5’-side, 94 
basepairs upstream of the 5’-end of the ACTH- 
coding region. No evidence for the presence of 
homologous equences in the further upstream 
region was provided by blot hybri~ation analysis 
of the phage DNA extending up to -7000 
basepairs upstream of the 5 ‘-end of the 
homologous pseudogene sequence; the 466 
basepair Bg(II-BarnHI fragment and the -1100 
basepair PstI-Bgn[I fragment, containing exon 1 
and exon 2 of the functional mouse gene, respec- 
tively (see fig. 1 A), were used as hybridization pro- 
bes. On the 3’-side, the sequence homology ends at 
the putative poly(A) addition site. In the 
pseudogene this site is followed by a 116 basepair 
segment composed mainly of repeated GA 
Volume 156, number 1 FEBS LETTERS June 1983 
dinucleotides. The 649 basepair pseudogene se- 
quence including the GA repeats, is flanked on 
both sides by direct repeats of the 10 basepair se- 
quence GGTTTTCTCA. This suggests the 
possibility that the pseudogene may have been 
generated by the formation of an aberrant 
transcript of the functional gene followed by the 
insertion of its DNA copy into the mouse genome, 
although a typical poly(A) tail is not found. This 
view is supported by our in vivo expression studies 
suggesting the aberrant initiation of transcription 
of the human ACTH-&LPH precursor gene 
around the site corresponding to the 5 ‘-end of the 
homologous pseudogene sequence ([20]; un- 
published). An RNA intermediate may be involved 
in the generation of some pseudogenes [21-261. In 
[27] the presence of a mouse pseudogene related to 
the ACTH-&LPH precursor gene was mentioned. 
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